Clincosm LogoSign in Get a demo

non small cell lung cancer

Showing 76 - 100 of 769
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer, Stage III Non-small-cell Lung Cancer Trial in United States (device, drug, radiation, procedure)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Stage III Non-small-cell Lung Cancer
  • Durvalumab
  • +4 more
  • Chicago, Illinois
  • +3 more
Jan 18, 2023

Solid Tumor, Non Small Cell Lung Cancer, Pancreatic Cancer Trial in Israel, United States (CM-24 and Nivolumab - Dose

Recruiting
  • Solid Tumor
  • +6 more
  • CM-24 and Nivolumab - Dose Escalation
  • +4 more
  • Scottsdale, Arizona
  • +10 more
Jan 17, 2023

Locally Advanced and Metastatic Non-Small Cell Lung Cancer

Recruiting
  • Non Small Cell Lung Cancer
  • Abbeville Cedex, France
  • +52 more
Jan 13, 2023

Non Small Cell Lung Cancer, Metastatic NSCLC, Recurrent Non Small Cell Lung Cancer Trial (Pembrolizumab, GT103)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • (no location specified)
Jan 12, 2023

Non Small Cell Lung Cancer, Stage IV NSCLC, Recurrent Non Small Cell Lung Cancer Trial in Tampa (biological, drug, other)

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Tumor-infiltrating Lymphocytes (TIL)
  • +5 more
  • Tampa, Florida
    Moffitt Cancer Center
Dec 28, 2022

Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Triple Negative Breast Cancer Trial in United States

Recruiting
  • Non Small Cell Lung Cancer
  • +11 more
  • Denver, Colorado
  • +3 more
Jan 10, 2023

Non Small Cell Lung Cancer Trial in Davis, Orlando, Columbus (ONC-392, Docetaxel)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Davis, California
  • +2 more
Jan 5, 2023

Immune Checkpoint Inhibitors in Non-Small Cell Lung Carcinoma

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Immune signature in serum associated to the metabolic signature
  • Meta-genomic signature of intestinal flora
  • La Tronche, Isère, France
    University Hospital, Grenoble
Jan 6, 2023

Non Small Cell Lung Cancer Trial in Hong Kong, Netherlands, Spain (Pulsed electric field treatment using the Aliya System)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Pulsed electric field treatment using the Aliya System
  • Sha Tin, Hong Kong
  • +3 more
Jan 6, 2023

Solid Tumor, Colorectal Cancer, Non Small Cell Lung Cancer Trial in United States (TPST-1495 twice daily, TPST-1495 once daily

Recruiting
  • Solid Tumor
  • +8 more
  • TPST-1495 twice daily
  • +2 more
  • Baltimore, Maryland
  • +8 more
Jan 4, 2023

Non Small Cell Lung Cancer, Stage I Lung Cancer, Stage Ib Lung Carcinoma Trial in Winston-Salem (Vitamin A Compound, Therapeutic

Active, not recruiting
  • Non Small Cell Lung Cancer
  • +5 more
  • Vitamin A Compound
  • Therapeutic Conventional Surgery
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Jan 5, 2023

Advanced Solid Tumor, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in United States (STK-012,

Recruiting
  • Advanced Solid Tumor
  • +10 more
  • Boston, Massachusetts
  • +8 more
Jan 2, 2023

Quality of Life and Physical Fitness After Immune Checkpoint

Completed
  • Melanoma
  • Non Small Cell Lung Cancer
    • Groningen, Netherlands
      University Medical Center Groningen
    Jan 3, 2023

    Non Small Cell Lung Cancer Trial in Pittsburgh (Fecal Microbiota Transplant (FMT), Pembrolizumab)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Dec 20, 2022

    Whole Blood From Active Non-Small Cell Lung Cancer Supplemental

    Recruiting
    • Non Small Cell Lung Cancer
    • Specimen sample
    • Waltham, Massachusetts
      Sanguine Biosciences
    Dec 28, 2022

    Non Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer Trial in Huntersville (FT536, Cyclophosphamide, Fludarabine)

    Recruiting
    • Non Small Cell Lung Cancer
    • +6 more
    • Scottsdale, Arizona
    • +4 more
    Dec 27, 2022

    Non Small Cell Lung Cancer Trial (Ensartinib Hydrochloride)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • Ensartinib Hydrochloride
    • (no location specified)
    Dec 15, 2022

    Gastric Cancer, Renal Cell Carcinoma, Melanoma Trial in United States (HFB200301)

    Recruiting
    • Gastric Cancer
    • +8 more
    • Scottsdale, Arizona
    • +9 more
    Dec 22, 2022

    Non Small Cell Lung Cancer, KRAS Activating Mutation Trial in Worldwide (VS-6766, VS-6766 and Defactinib)

    Recruiting
    • Non Small Cell Lung Cancer
    • KRAS Activating Mutation
    • avutometinib (VS-6766)
    • avutometinib (VS-6766) and Defactinib
    • Duarte, California
    • +44 more
    Dec 22, 2022

    Non Small Cell Lung Cancer, KRAS Activating Mutation, Advanced Cancer Trial in United States (VS-6766 and adagrasib)

    Recruiting
    • Non Small Cell Lung Cancer
    • +5 more
    • avutometinib (VS-6766) and adagrasib
    • San Francisco, California
    • +4 more
    Dec 21, 2022

    Solid Tumor, Advanced Solid Tumor, Non Small Cell Lung Cancer Trial in Denver, Nashville, Fairfax (MRTX0902, MRTX849)

    Recruiting
    • Solid Tumor
    • +3 more
    • Denver, Colorado
    • +2 more
    Dec 19, 2022

    Non Small Cell Lung Cancer, Lung Cancer Trial in Los Angeles (Osimertinib, Carotuximab)

    Recruiting
    • Non Small Cell Lung Cancer
    • Lung Cancer
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Dec 20, 2022

    Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Metastatic, Non-small Cell Carcinoma Trial in United States (radiation,

    Recruiting
    • Non Small Cell Lung Cancer
    • +4 more
    • L-SABR
    • +2 more
    • Basking Ridge, New Jersey
    • +6 more
    Dec 20, 2022

    Non Small Cell Lung Cancer Trial in Ostrava (Chemotherapy, Radiotherapy (RT) + Stereotactic Body Ratio Therapy (SBRT),

    Recruiting
    • Non Small Cell Lung Cancer
    • Chemotherapy
    • +2 more
    • Ostrava, Moravian-Silesian Region, Czechia
      University Hospital Ostrava
    Dec 19, 2022

    KRAS P.G12C, Non Small Cell Lung Cancer Trial in France (Sotorasib 120Mg Tab)

    Recruiting
    • KRAS P.G12C
    • Non Small Cell Lung Cancer
    • Sotorasib 120Mg Tab
    • Lyon, France
    • +3 more
    Dec 16, 2022